Figure 3
From: Novel candidate factors predicting the effect of S-1 adjuvant chemotherapy of pancreatic cancer
Recurrence free survival after combining C1TC and SAHH. There were 23 cases of both C1TC and SAHH showed positive expression, 8 cases showed both negative expressions, 8 cases showed only SAHH positive and 8 cases of C1TC positive respectively. Double positive group showed a significant improvement of RFS compared to No adjuvant group. On the other hands, when C1TC and/or SAHH was negative, there was no significant difference compared with no adjuvant group. When C1TC and/or SAHH negative cases was combined into one group and compared with double positive or No adjuvant group, RFS was dramatically worse compared with double positive group and almost similar with No adjuvant group.
